Marketing Resources
Morbi porta, velit consectetur vehicula suscipit, ligula urna lacinia lectus, sit amet semper massa nibh vitae.
Biom ODD Filing
Biom Therapeutics filed Orphan Drug Designation for BIO017 with the FDA Published: ...
Positive results from Lead drug candidate
Biom Therapeutics, LLC announces positive results from Phase 2 clinical trial for rare epilepsy ...
BioFlorida Finalist
Biom Therapeutics selected as a finalist at BioFlorida annual Biopitch competition for early-stage life ...
Events
Events
News
News Biom Completes safety and efficacy data of ...
Scientific Publication
Scientific Publications Cannabidiol for the Treatment of Drug-Resistant Epilepsy ...